TransDigm grants director Michael Graff 589 options
The options become exercisable in annual 20% increments beginning September 30, 2027, subject to annual operating performance targets.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TransDigm Group (TDG) director Michael Graff was granted 589 stock options on November 3, 2026, with an exercise price of $1,208.04 per share. The options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets in each year. They expire November 3, 2036; following the grant, 589 options were reported as directly held.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 589 | $0.00 | $0.00 |
Footnotes (1)
- F1. These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year.
Key Figures
Key Terms
Stock Option technical
exercise price financial
exercisable technical
annual operating performance targets technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many stock options did TransDigm director Michael Graff receive?
When can Michael Graff's TransDigm stock options be exercised?
AI-generated analysis. How Rhea-AI works. Not financial advice.